← Open Payments lookup

LAUREN WOODWARD: Open Payments

NPI 1942896808 · KING OF PRUSSIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,293 in 59 payments from 13 companies in 2025. Trend: 2023 $1,066 · 2024 $2,750 · 2025 $1,293

Food & beverage: $1,293
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$270
CSL Behring8$208
GlaxoSmithKline, LLC.9$187
GENZYME CORPORATION8$162
Takeda Pharmaceuticals U.S.A., Inc.5$120
Genentech USA, Inc.4$102
Azurity Pharmaceuticals, Inc.2$54
Regeneron Healthcare Solutions, Inc.3$45
Grifols USA, LLC1$38
Hikma Pharmaceuticals USA2$37

Products named: DUPIXENT, Hizentra, FASENRA, Xolair, CUVITRU, TEZSPIRE, TRELEGY ELLIPTA, NUCALA.

Industry payments across PA — which companies pay providers there.